Esperto Medical
Series A in 2024
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostics for both hospital and remote patient monitoring. The company utilizes innovative resonance sonomanometry technology, which employs acoustic stimulation to provide continuous and noninvasive blood pressure measurements without the need for calibration. By enabling round-the-clock monitoring of vital signs, Esperto Medical’s devices aim to enhance accessibility to medical care through automation, allowing patients to effectively manage their health from home or within clinical settings.
Feno is a pioneering oral health company that aims to improve overall health by addressing oral health issues. It develops innovative, tech-driven products such as the 20-second Feno Smartbrush, an at-home oral scanner, and AI-powered digital oral health coaches. These solutions, which leverage advanced technologies and proprietary formulations, empower individuals to take control of their oral health, thereby potentially reducing the risk of systemic health conditions like heart disease, stroke, and diabetes.
Viome Life Sciences
Series D in 2024
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Viome Life Sciences
Series C in 2023
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Solarea Bio
Series B in 2023
Solarea Bio, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing microbial therapeutics to address health disorders linked to chronic inflammation. Founded in 2017, the company utilizes a platform that combines microbial discovery and genomics to create synergistic microbial assemblages using bacteria and fungi derived from healthy foods. Solarea Bio generates an extensive database of complete genomic sequences of these microbes and employs computational approaches to formulate combinations that exhibit strong anti-inflammatory properties. The company's therapeutics aim to prevent or mitigate health issues associated with chronic inflammation, with initial applications targeting dietary management of metabolic conditions like osteopenia and osteoporosis in postmenopausal women. Through its innovative approach, Solarea Bio seeks to enhance the quality of life by providing nature-based solutions for various health challenges.
Viome Life Sciences
Series C in 2022
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
KeyCare is a virtual care platform that leverages the Epic system to support health systems in enhancing patient access and quality of care. The platform is designed to provide a tech-driven virtual care team that supplements existing healthcare workforces, thereby broadening the options available for virtual care. By focusing on increasing accessibility and improving care quality, KeyCare aims to meet the needs of patients and healthcare providers in a rapidly evolving healthcare landscape.
Viome Life Sciences
Series C in 2021
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Meru Health
Series B in 2021
Meru Health, Inc. is a digital healthcare company based in San Mateo, California, with additional offices in Palo Alto, California, and Helsinki, Finland. Founded in 2015, it specializes in providing a mobile application that connects patients with licensed therapists through a structured 12-week program aimed at addressing mental health issues such as stress, depression, anxiety, and burnout. The platform combines continuous remote clinician support with at-home lessons and practices, including cognitive behavioral therapy and coaching in sleep and nutrition. By offering cost-effective and clinically proven digital therapeutic solutions, Meru Health empowers individuals to improve their mental well-being while also aiming to reduce overall healthcare costs.
Solarea Bio
Series A in 2020
Solarea Bio, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing microbial therapeutics to address health disorders linked to chronic inflammation. Founded in 2017, the company utilizes a platform that combines microbial discovery and genomics to create synergistic microbial assemblages using bacteria and fungi derived from healthy foods. Solarea Bio generates an extensive database of complete genomic sequences of these microbes and employs computational approaches to formulate combinations that exhibit strong anti-inflammatory properties. The company's therapeutics aim to prevent or mitigate health issues associated with chronic inflammation, with initial applications targeting dietary management of metabolic conditions like osteopenia and osteoporosis in postmenopausal women. Through its innovative approach, Solarea Bio seeks to enhance the quality of life by providing nature-based solutions for various health challenges.
Deep Longevity
Series A in 2020
Deep Longevity, Inc. is a biotechnology company focused on developing innovative solutions for aging and longevity. Founded in 2016 and based in Hong Kong, the company specializes in creating aging and longevity clocks tailored for preventative medicine organizations, health clubs, insurance companies, and aging centers. Its offerings include Longevity Cloud, a platform that hosts deep aging clocks, and Young.AI, a web and mobile application designed to support longevity initiatives. Deep Longevity also develops multifactorial tools known as deep aging clocks to measure biological age, alongside a recommendation engine aimed at suggesting longevity interventions. The company employs advanced AI techniques to harness various data types, including clinical blood tests and other biological metrics, to enhance the accuracy of biological age predictions.
Gali Health
Seed Round in 2020
Gali Health, Inc. is a health technology company based in San Francisco, California, founded in 2015. The company has developed a mobile application called Gali, which serves as a personal health assistant aimed at individuals with chronic conditions. Gali leverages collective intelligence and artificial intelligence to analyze health data, providing users with personalized support regarding medical, lifestyle, and psychological aspects of managing their health. The platform focuses on empowering users by crowdsourcing health information and delivering medically-validated insights, enabling proactive health management. Gali Health's mission is to ensure that individuals dealing with chronic illnesses do not feel isolated or powerless, advancing consumer-driven healthcare through innovative technology.
Meru Health
Series A in 2020
Meru Health, Inc. is a digital healthcare company based in San Mateo, California, with additional offices in Palo Alto, California, and Helsinki, Finland. Founded in 2015, it specializes in providing a mobile application that connects patients with licensed therapists through a structured 12-week program aimed at addressing mental health issues such as stress, depression, anxiety, and burnout. The platform combines continuous remote clinician support with at-home lessons and practices, including cognitive behavioral therapy and coaching in sleep and nutrition. By offering cost-effective and clinically proven digital therapeutic solutions, Meru Health empowers individuals to improve their mental well-being while also aiming to reduce overall healthcare costs.
Gali Health
Seed Round in 2019
Gali Health, Inc. is a health technology company based in San Francisco, California, founded in 2015. The company has developed a mobile application called Gali, which serves as a personal health assistant aimed at individuals with chronic conditions. Gali leverages collective intelligence and artificial intelligence to analyze health data, providing users with personalized support regarding medical, lifestyle, and psychological aspects of managing their health. The platform focuses on empowering users by crowdsourcing health information and delivering medically-validated insights, enabling proactive health management. Gali Health's mission is to ensure that individuals dealing with chronic illnesses do not feel isolated or powerless, advancing consumer-driven healthcare through innovative technology.
Viome Life Sciences
Series B in 2019
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
Viome Life Sciences
Series A in 2017
Viome Life Sciences, established in 2016 and headquartered in Bellevue, Washington, specializes in providing comprehensive health insights through its proprietary at-home clinical-grade tests. The company analyzes RNA from stool samples, along with other bodily fluids, to determine the makeup of microbial communities, offering personalized recommendations for diet and lifestyle based on the results. Viome's services aim to empower individuals to track their microbiome health, mitochondrial health, cellular health, and biological age, ultimately aiding in the prevention and reversal of chronic diseases. The company operates as a subsidiary of BlueDot LLC and sells its products through distributors and online channels.